2012, FDA, Licensing and Medicare - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2012

FDA

Licensing

Medicare

CMS Updates IPPS Rates, Wage Index and DSH Uncompensated Care in 2024 Final Rule

Hall Render

AUGUST 10, 2023

On August 1, 2023, the Centers for Medicare & Medicaid Services (“CMS”) issued its Final Hospital Inpatient Prospective Payment System (“IPPS”) and Long-Term Care Hospital (“LTCH”) PPS rule for fiscal year (“FY”) 2024 (“Final Rule”). The Final Rule increases the rate for IPPS payments by 3.3% in FY 2024 but applies a 0.2%

Hospitals

Hospitals Medicare Medicare Medicaid

FDA and Off-Label Communication – Getting Closer to Truth

Drug & Device Law

NOVEMBER 9, 2023

In addition to its recent revamp of its “§510(k)” substantial equivalence clearance process for medical devices, (see our post here ), the FDA has also been active with respect to off-label communications – another regulatory area of continuing interest to this Blog. 2012); Amarin Pharma, Inc. FDA , 119 F. Caronia , 703 F.3d

FDA

FDA Health Insurance Nurses Medicare

CMS Updates IPPS Rates, Wage Index and DSH Uncompensated Care in 2024 Final Rule

FDA and Off-Label Communication – Getting Closer to Truth

Stay Connected